<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00774098</url>
  </required_header>
  <id_info>
    <org_study_id>SDR-06-012</org_study_id>
    <nct_id>NCT00774098</nct_id>
  </id_info>
  <brief_title>Improving Glycogen Liver Content Will Improve Post-operative Liver Function in Patients Undergoing Major Liver Resections</brief_title>
  <official_title>Improving Glycogen Liver Content Will Improve Post-operative Liver Function in Patients Undergoing Major Liver Resections</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>McGill University Health Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>McGill University Health Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      We would like to study the effect of preserving liver glycogen storage by using intravenous
      dextrose infusion on postoperative liver function and complications after major liver
      resections.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2007</start_date>
  <completion_date type="Actual">September 2009</completion_date>
  <primary_completion_date type="Actual">September 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Postoperative liver function test</measure>
    <time_frame>Postoperative</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Liver and muscle glycogen, TG, and protein content at beginning and end of the procedure.</measure>
    <time_frame>Begining + end of the procedure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of complications</measure>
    <time_frame>Postoperative</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Liver Function</condition>
  <arm_group>
    <arm_group_label>Control Group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Intravenous normal saline (NS 0.9) started just before induction, and titrated to hemodynamic parameters and urine output</description>
  </arm_group>
  <arm_group>
    <arm_group_label>GICP</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>dextrose 10% (D10W Â®) infusion</intervention_name>
    <description>Started at 8pm the day before surgery until the procedure begins</description>
    <arm_group_label>GICP</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>hyperinsulinemic normoglycemic clamp</intervention_name>
    <description>Started as the procedure begins, decreased at the end of the procedure and continued until 16 hours postoperatively</description>
    <arm_group_label>GICP</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>high calorie diet 35 kcal/kg</intervention_name>
    <description>High Calorie meals start the day before the surgery and are given 5 hours apart. The last meal is given at 7 pm the day before surgery</description>
    <arm_group_label>GICP</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Intravenous normal saline (NS 0.9)</intervention_name>
    <description>Intravenous normal saline (NS 0.9) started just before induction, and titrated to hemodynamic parameters and urine output</description>
    <arm_group_label>Control Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18 years or older

          -  planned to undergo a major liver resection at McGill University Health Center (MUHC)

        Exclusion Criteria:

          -  patients known with chronic viral liver disease

          -  uncontrolled or type one diabetes mellitus (DM)

          -  patients on oral beta-blocker agents

          -  patients with unresectable disease determined intra-operatively

          -  patients unable to give consent for the study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Royal Victoria Hospital</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H3A1A1</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>March 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 15, 2008</study_first_submitted>
  <study_first_submitted_qc>October 16, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 17, 2008</study_first_posted>
  <last_update_submitted>March 31, 2010</last_update_submitted>
  <last_update_submitted_qc>March 31, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 1, 2010</last_update_posted>
  <responsible_party>
    <name_title>Dr Peter Metrakos</name_title>
    <organization>MUHC</organization>
  </responsible_party>
  <keyword>all adult patients (&gt;18 years) planned to undergo a major liver resection</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

